The U.S. cannabis industry is hitting a major turning point today. Federal officials are moving forward with reclassifying marijuana under the Controlled Substances Act. For years, cannabis sat in the strictest category, Schedule I. That placed it next to drugs considered to have no medical value. Now, it is being shifted toward Schedule III. This is a big change in how the government views cannabis.

To be clear, this is not full legalization. However, it is still a meaningful step forward. Schedule III recognizes that cannabis has medical use and a lower risk than before. As a result, cannabis companies could finally see real benefits. For example, they may get relief from heavy tax burdens. They could also gain better access to research and outside investment.

For years, these companies have been operating under tough financial conditions. They have not been allowed to deduct normal business expenses. That has made profitability much harder to achieve. Now, that could begin to change. As a result, investors are watching closely for how quickly these updates take effect.

At the same time, there are still some unknowns. This change will not instantly fix every issue in the industry. State laws will remain the same for now. Interstate commerce is also still restricted. Even so, this is one of the biggest federal moves the cannabis space has seen in decades.

As a result, market sentiment is shifting. Cannabis stocks are becoming more active again. Traders are focusing on key levels and setups. If momentum builds, the sector could see a strong move higher.

[Read More]3 Marijuana Stocks To Watch In 2026 For Better Trading

The U.S. cannabis sector continues evolving, even as volatility remains elevated. Many investors are now watching penny stocks for potential upside. These lower-priced names often carry a higher risk. However, they can also deliver strong percentage gains. Therefore, traders are focusing on companies with real revenue and growing footprints.

At the same time, the broader industry still shows long-term growth potential. Legal cannabis sales in the U.S. remain in the tens of billions annually. Furthermore, expansion into new states continues to support future demand. As a result, penny stocks with strong operations may benefit the most. Still, proper risk management and technical analysis remain essential for trading success.

Ascend Wellness Holdings is a vertically integrated cannabis operator in the United States. The company operates across several key markets. These include Illinois, Michigan, Massachusetts, New Jersey, and Ohio. As a result, it has built a strong multi-state footprint.

The company focuses on cultivation, manufacturing, and retail distribution. It operates dozens of dispensaries across its core states. Its largest presence remains in Illinois and New Jersey. These are two of the most competitive cannabis markets.

Source: Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™